Workflow
OKYO Pharma(OKYO)
icon
Search documents
OKYO Pharma(OKYO) - Prospectus(update)
2023-02-17 21:06
(Exact name of Registrant as specified in its charter) As filed with the Securities and Exchange Commission on February 17, 2023. Registration Statement No. 333-268675 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 4 to Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OKYO Pharma Limited Not Applicable (Translation of Registrant's name into English) OKYO Pharma Limited Martello Court Admiral Park St. Peter Port Guernsey GY1 3HB +44 (0)20 7495 2379 (Addr ...
OKYO Pharma(OKYO) - Prospectus(update)
2023-01-19 17:13
As filed with the Securities and Exchange Commission on January 19, 2023. Registration Statement No. 333-268675 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 3 to Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OKYO Pharma Limited (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) OKYO Pharma Limited Martello Court Admiral Park St. Peter Port Guernsey GY1 3HB +44 (0)20 7495 2379 (Addre ...
OKYO Pharma(OKYO) - Prospectus(update)
2023-01-03 22:25
As filed with the Securities and Exchange Commission on January 3, 2023. Registration Statement No. 333-268675 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 2 to Form F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OKYO Pharma Limited (Exact name of Registrant as specified in its charter) Not Applicable (Translation of Registrant's name into English) OKYO Pharma Limited Martello Court Admiral Park St. Peter Port Guernsey GY1 3HB +44 (0)20 7495 2379 (Addres ...
OKYO Pharma(OKYO) - 2022 Q4 - Annual Report
2022-08-15 19:51
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ...